Fundraising Fox
🦊/Companies
Sign in

Lunaphore

Lausanne, CH · 4 known investors

Find your way into Lunaphore

Lunaphore develops spatial biology solutions that enable scientists and clinicians to analyze tissue structure and cellular composition. The company was acquired by Bio-Techne in 2023 to expand the combined entity's capabilities in applied spatial biology.

BiotechDeep TechMedical Devices

Investors · 4

OCCIDENTMunich
Polytech Ecosystem Ventures
Zühlke VenturesZurich · $165K – $275K

Also in the syndicate · 1

Ernst-Göhner Stiftung Beteiligungen (EGSB)lead

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries D1Mar 2023

    Ernst-Göhner Stiftung Beteiligungen (EGSB) (lead)

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Lunaphore secures CHF 40 million to boost portfolio of tissue diagnostics solutionsventurelab.swiss · Mar 2023Lunaphore Raises CHF40M in Series D Funding For Spatial Biologyfinance.yahoo.com · Mar 2023Lunaphore Technologies Raises Additional $2.1M in Series C Financing | Genomewebgenomeweb.com · Apr 2020Lunaphore Raises €21.5M to Develop Automated Cancer Research Toolslabiotech.eu · Feb 2020Lunaphore Technologies Raises CHF 23M in Series C Financing | 360Dx360dx.com · Feb 2020Lunaphore Closes CHF5.3M Series B Financing Round - FinSMEsfinsmes.com · Aug 2018

Frequently asked questions

What does Lunaphore do?
Lunaphore develops spatial biology solutions that enable scientists and clinicians to analyze tissue structure and cellular composition. The company was acquired by Bio-Techne in 2023 to expand the combined entity's capabilities in applied spatial biology.
Who are Lunaphore's investors?
Lunaphore's investors include OCCIDENT, Polytech Ecosystem Ventures, Zühlke Ventures.
Where is Lunaphore headquartered?
Lunaphore is headquartered in Lausanne, CH.